Adverse Drug Reaction & Quality Defect Reporting
Report a suspected side effect
The Health Products Regulatory Authority (HPRA) monitors the safety and quality of all authorised medicines on the Irish market and part of this activity is carried out through the review and evaluation of suspected adverse drug reactions (ADRs) and quality defects.
All healthcare professionals are encouraged to use the national reporting system to report suspected adverse effect in one of the following ways:
To report a suspected quality defect, you can:
- Use the HPRA’s online reporting system
- Email: email@example.com
- Post: Compliance Department – Quality DefectsHealth Products Regulatory AuthorityKevin O'Malley House, Earlsfort CentreEarlsfort Terrace, Dublin 2
- Pharmacists may use the HPRA postage-paid 'green card' to report suspected quality defects, which is available upon request from the Market Compliance Section.
- Fax: +353-1-6764061 (Note: Fax machine is manned during office hours only)
- Telephone: (01) 6764971
Leaflets for people with sight challenges (XPIL)
Some pharmaceutical companies have chosen to display their Patient Information Leaflets (PIL) in PDF format and also as a text only version, called an XPIL. The XPIL is designed for people with sight challenges and can be read by screen readers, or printed in large print.